GLAAD reported on Thursday that most Americans say they have not seen stories about people living with HIV in the media. In ...

The 2026 State of HIV Stigma Report released by GLAAD shows a growing divide between medical progress and public ...

A cure for HIV would be one of the greatest medical achievements in modern history. But the day a cure is celebrated could ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...

Second Study in ACTG’s Small Clinical Trials Advancing HIV Remission and Cure ProgramCHAPEL HILL, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and ...

For the past four decades, oral antiretroviral therapy for HIV has required daily doses. Long-acting injectable cabotegravir ...

It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NAKURU, KENYA - 2026/03/26: A healthcare worker fills a syringe with a dose of lenacapavir, ...

A similar model of bringing testing into less engaged communities could potentially be implemented elsewhere with adequate funding, resources, and buy-in.